Can't sleep? We asked the experts if cortisol addiction is keeping you awake — and what you can do about it
When you buy through links on our articles, Future and its syndication partners may earn a commission.
The constant go-go-go of life can feel like you never get a chance to slow down, even when you're actively trying to rest. And when you do stop to breathe, your busy mind prevents you from properly switching off.
Social media has a name for this — cortisol addiction.
"The concept of cortisol addiction has gained a lot of attention on social media," explains Dr. Leah Kaylor, a licensed psychologist specializing in sleep. "It's used to explain symptoms like constant busyness, restlessness, difficulty relaxing, or poor sleep."
'Cortisol addiction' isn't without its controversy, as we found out when we asked the experts.
But with so many adults experiencing insomnia or sleep deprivation, we're exploring how cortisol impacts sleep, if we can become addicted to it, and how to naturally lower cortisol levels.
'Cortisol addiction' has become a social media buzzword, describing stress-seekers; you scroll through your phone when you're busy, you struggle to sit still and feel guilty when you take a moment to relax.
But cortisol itself isn't the bogeyman it first appears to be. "Cortisol is a hormone that we make and need in various amounts, every moment of the day," explains Dr. Thara Vayali, naturopathic doctor and co-founder of hey freya.
People become used to being 'in go mode' all the time
Part of cortisol's impact is mediating the stress response — that fight-or-flight instinct that allows you to deal with high-stakes situations. It also acts like a natural wake up call, as increasing cortisol levels signal to your body it's time to be alert.
Dr. Vayali explains that social media uses the term 'cortisol addiction' to describe becoming accustomed to the increased energy that comes from high cortisol levels as a response to stress.
However, while extra energy can be a benefit when you're feeling pressure, this effect of cortisol also has its disadvantages.
"People become used to being 'in go mode' all the time," says Dr. Emma Lin, Sleep Medicine Specialist. "The body becomes used to being stressed. Then, when you are meant to relax, you can't."
Like many social media trends, cortisol addiction has its critics. Including Dr, Ruchir Patel, founder of the Insomnia and Sleep Institute of Arizona.
"Cortisol addiction is not a medical terminology but, rather, a social media trend," says Dr. Patel. "If anything it is stress addiction that results in high cortisol levels and impacts energy levels and sleep."
"If you look into the DSM5 and ICD11, cortisol addiction is not listed as a medically recognized diagnosis," agrees Dr. Kaylor. "There is not peer reviewed psychiatric literature as a formal disorder."
But while she explains there is "no empirical evidence that cortisol itself is addictive," she does point out that some of us might be "creating a cycle that mimics addictive behavior."
"Habitual engagement in high-stress or high-stimulation environments may reinforce behavior through the pleasure seeking hormone, dopamine," explains Dr. Kaylor.
"Over time, individuals may unconsciously seek out stress-inducing activities that elevate cortisol, which they associate with productivity, control, or even identity."
Dr. Vayali similarly agrees, noting that while cortisol is not an addictive substance, some people "create or search for high stress situations because of the reward they receive from these situations."
During moments of stress the energy boost of increased cortisol allows you to better tackle the problem at hand.
But once that stress has gone, your body needs time to rebalance your cortisol.
Persistently elevated cortisol directly interferes with sleep architecture
If you're experiencing cortisol addiction (or frequently seeking pressure for the associated energy burst), your cortisol levels are likely to remain elevated. And this is bad for your sleep.
"Persistently elevated cortisol directly interferes with sleep architecture," says Dr. Vayali.
"Normally cortisol follows a circadian rhythm, peaking in the morning and declining by evening. But high stress environments flatten this curve, keeping levels high at night."
Dr. Lin describes the result as "tired but wired." Your body might be ready to drop off but your racing mind impacts your sleep in the following ways:
The time it takes to fall asleep is known as sleep latency and for the average person it lasts around 10 to 20 minutes.
However, if you have a cortisol addiction (or display the behaviors sometimes described as a cortisol addiction), you might find it takes significantly longer to drift off.
"Elevated evening cortisol levels are associated with delayed sleep onset," says Dr. Kaylor. "This is because cortisol promotes alertness."
(It's worth noting that falling asleep as soon as your head hits the pillow also isn't desirable. This is likely a sign you're experiencing sleep deprivation.)
While waking up in the night is normal, those with consistently high cortisol levels might find they wake up regularly and struggle to fall back to sleep.
"High cortisol levels have been linked to increased sleep fragmentation, leading to more frequent awakenings and reduced deep sleep," describes Dr. Kaylor.
And even if by bedtime you feel as though the day's stresses are behind you, cortisol addiction can still prevent you from achieving deep sleep.
"A persistently overactive stress system during the day can heighten arousal, making it difficult for the body to enter restorative sleep," notes Dr. Kaylor.
For those with increased cortisol levels, what feels like a full night's rest might not be as restorative as you hoped. As Dr. Lin put it; "when you wake up, you are as tired as when you went to bed."
If this becomes a reoccurring problem, consistently high cortisol levels can potentially lead to long-term sleep deprivation.
"Prolonged daytime stress primes the hypothalamic-pituitary-adrenal (HPA) axis to remain hyperactive, fragmenting sleep quality." explains Dr. Vayali.
"Over time, this can create a vicious cycle: poor sleep further dysregulates cortisol, exacerbating stress, and perpetuates the feeling of exhaustion despite feeling wired."
It's not possible to 'quit' a cortisol addiction. As Dr. Vayali points out; "you cannot wean yourself off a hormone that you require everyday."
However, there are methods you can use to naturally balance cortisol levels. Dr. Lin describes it as your body learning "that it's acceptable to relax."
Relaxing doesn't always come easy, particularly if elevated cortisol levels leave you itching to get up and do something.
Mindfulness for better sleep aims not only to help you drift off but also to teach you to find calm.
"Regular mindfulness practice has been shown to lower cortisol levels and improve sleep quality," explains Dr. Kaylor.
"Breathwork and progressive muscle relaxation can help shift the brain and body towards a state of relaxation and away from stress."
And it doesn't need to be a complex yoga routine or guided meditation.
"Relax and take a deep breath," Dr. Lin suggests. "Stretching, deep breathing, or even just sitting peacefully can help your body realize it's time to relax."
Compensating for your high-stress week by crashing out on the weekend might seem sensible but this changeable routine is bad for your circadian rhythm, which in turn disrupts your cortisol cycle.
"Consistency, consistency, consistency" emphasizes Dr. Kaylor, "with the time in which you go to bed and the time in which you wake up — even on weekends, even on holidays! (bummer, I know.)"
This consistency reinforces your circadian rhythm, while a varying sleep routine can cause social jet lag; a groggy feeling as though you're constantly changing time zones.
Social media might be flooded with foods to send you to sleep, but Dr. Kaylor suggests you're better off adjusting your meal timings if you want to support your rest.
"Finish your last meal of the day and no more alcohol 3 hours before bed," she advises. "Digesting food is an energy-intensive process... Eating late forces these organs to remain active when they should be resting"
And, of course, stay away from coffee.
"Cut out caffeine 10 hours before bed," says Dr. Kaylor. "By blocking adenosine, caffeine keeps your brain in a state of heightened alertness, even when your body is signaling that it's time to rest."
As well as avoiding obvious culprits, such as coffee and energy drinks, she advices to stay alert for "sneaky sources of caffeine" including pre-workout supplements.
Bedtime routines aren't just for children, as winding down in the evening helps you achieve the calm headspace needed for sleep.
"As adults we have the tendency to go go go," says Dr. Kaylor.
"Many times when people complain of difficulties with sleep it is because they are expecting their body to be able to shift gears from the busyness of the day into a state conducive to sleep immediately and that's simply not how it works."
Dr. Kaylor notes that your routine should be based on your needs but she has some suggestions to get started, including taking a bath, listening to calm music or adopting a "quiet hobby" such as knitting or journaling.
Dr. Lin suggests a similar focus on calm; "avoid stressful conversations, homework, or intense video games before bed."
But if you've been relying on an evening work out to let go off stress and induce fatigue, Dr. Vayali recommends caution.
"While more intense or energetic cardio lowers baseline cortisol, working out at night can prolong cortisol elevation temporarily," advises Dr. Vayali.
"When considering evening movement, focus on earlier, and something that prioritizes deep breathing."
To keep your cortisol levels balanced, consider what you do when they first start rising in the morning.
"A very easy tip is to get sunlight exposure," explains Dr. Kaylor. "This is one of the most effective ways to strengthen the circadian rhythm, which is the body's internal clock that regulates our sleep-wake cycle."
Dr. Vayali suggests pairing morning sunlight with "non-alarming wake sounds" — few things get the pressure levels rocketing quite like a screeching alarm. A gentler sound starts your day on a more even keel.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
Just 1 dose of magic mushroom compound eases depression for at least 5 years in most patients, small study suggests
When you buy through links on our articles, Future and its syndication partners may earn a commission. DENVER—Psilocybin, the main psychoactive ingredient in magic mushrooms, can alleviate depression for at least five years after a single dose, a new study finds. The research, presented June 18 at the Psychedelic Science 2025 conference in Denver, focused on patients with major depressive disorder (MDD), which is often called clinical depression. The serious mood disorder causes a persistent feeling of sadness and a loss of interest or pleasure in activities that were once enjoyable. The most common treatments for MDD include talk therapy and medications such as selective serotonin reuptake inhibitors, and both can take a long time to show any benefits. When early studies hinted at psilocybin's potential as an antidepressant, a team of researchers undertook the first-ever randomized clinical trial to explore the use of the psychedelic for treating severe depression. The trial included 24 patients, half of whom received psilocybin at the very start of the trial and half of whom received the same dose eight weeks later—the "waitlist" group. Each patient also received 11 hours of psychotherapy. Even in that short time frame, "there was a significant reduction in depression in the immediate-treatment group compared to those on the waitlist," study co-author Alan Davis, director of the Center for Psychedelic Drug Research and Education at The Ohio State University, told Live Science. Once all of the patients had completed the four-week study, the psilocybin appeared to be four times more effective than traditional antidepressant medications, based on previous research data. One month after the treatment, 17 patients had relieved symptoms, including 14 who were in full remission from depression. Patients also responded much faster to psilocybin than is typical for conventional antidepressants. But do these benefits of psilocybin last? Related: Magic mushrooms temporarily 'dissolve' brain network responsible for sense of self Very few long-term studies of psilocybin for depression have been conducted to date, said Dr. Charles Raison, a professor of human ecology and psychiatry at the University of Wisconsin-Madison who was not involved in the research. "They are very difficult to do because people drop out," Raison told Live Science in an email. "But also because they go on all sorts of other treatments that obfuscate the degree to which any longer lasting benefits result from the psychedelic or because the participant got therapy or restarted an antidepressant." To investigate whether the benefits for psilocybin lasted and if the patients had experienced any side effects, the researchers contacted the original trial participants several years later to request their enrollment in a follow-up study. Twenty-one patients enrolled, and their clinicians rated any changes in the participants' levels of depression from before the original treatment to the present day. The patients also filled out a series of self-reported, online questionnaires and met up with clinicians to document their ability to engage in everyday tasks, their levels of anxiety and their general mental health. The researchers assumed that the three patients that didn't sign up for the follow up, and the three that didn't complete the questionnaires had not remained in remission. Even so, the researchers found that 67% of the participants who had suffered from depression half a decade earlier remained in remission after a single psychedelic therapy session. These patients also reported less anxiety and less difficulty functioning on a daily basis. In general, the two-thirds of the patients who responded well reported lasting positive changes in their mindsets, emotional health and relationships. "I'm excited by these deeper aspects of their lives that really speaks to the importance of these interventions beyond just reduction of depression," Davis said. RELATED STORIES —Psychedelics rapidly change the brain. Here's how. —Australia clears legal use of MDMA and psilocybin to treat PTSD and depression —'Magic mushroom' treatment for depression inches closer to approval Most of the patients shared that, following the original treatment, they'd engaged in self-reflection and therapy to help understand themselves and navigate life's challenges. Davis hypothesizes that the psychedelic experience catalyzes a deeper therapy process and would like to conduct future studies comparing the relative influences of psilocybin and psychotherapy in alleviating depression. "The biggest caveat of this study is the small sample size, and the fact that the original trial showed larger antidepressant effects than subsequent larger multi-site studies seem to be showing," Raison said. In a multi-site clinical trial with 233 participants, 37% of the 79 who received a single 25 mg dose of psilocybin, coupled with psychotherapy, went into remission from major depression. While these trials report less widespread antidepressant effects, they support the idea that psilocybin can effectively treat depression, Davis said, and he is keen to see how the findings of multi-site trials hold up five years post-treatment.
Yahoo
a day ago
- Yahoo
Science news this week: 'Dragon Man's' identity and the universe's 'missing matter'
When you buy through links on our articles, Future and its syndication partners may earn a commission. This week's science news reveals the identity of the mysterious "Dragon Man," while also finding clues to the universe's "missing matter." In 1933, a Chinese laborer in Harbin City discovered a human-like skull with a huge cranium, broad nose and big eyes. Just under 90 years later, experts gave this curious specimen a new species name — Homo longi, or "Dragon Man" — due to its unusual shape and size. But this classification has not gone unchallenged, with many scientists saying this skull belongs not to a new species, but instead to an ancient group of humans called Denisovans. Now, a pair of new studies claim to have finally put the mystery to bed. Another mystery that we came one step closer to solving this week is where the universe's "missing" matter is hiding. Ordinary or "baryonic" aryonic matter, which is composed of particles like protons and neutrons, makes up just 5% of the universe, but scientists have been able to observe only about half as much of it as they expected. To find the missing matter, researchers search for clues by studying short, extragalactic flashes known as fast radio bursts, which light up the intergalactic space that lies between them and Earth — and they may have just found some. Although very few long-term studies of psilocybin — the main psychoactive ingredient in magic mushrooms — as a treatment for depression have been conducted to date, new research presented this week at the Psychedelic Science 2025 conference suggests it can alleviate depression for at least five years after a single dose. The researchers found that 67% of study participants who had suffered from depression half a decade earlier remained in remission after a single psychedelic therapy session, while also reporting less anxiety and less difficulty functioning on a daily basis. Discover more health news —Iron deficiency in pregnancy can cause 'male' mice to develop female organs —The brain might have a hidden 'off switch' for binge drinking —Ketamine may treat depression by 'flattening the brain's hierarchies,' small study suggests The world is awash with the color purple — lavender flowers, amethyst gemstones, plums, eggplants and purple emperor butterflies. But if you look closely at the visible-light portion of the electromagnetic spectrum, you'll notice that purple is absent. So does that mean the color doesn't really exist? Not necessarily. —If you enjoyed this, sign up for our Life's Little Mysteries newsletter Asking artificial intelligence reasoning models questions on topics like algebra or philosophy caused carbon dioxide emissions to spike significantly. Specialized large language models (LLMs), such as Anthropic's Claude, OpenAI's o3 and DeepSeek's R1, dedicate more time and computing power to producing more accurate responses than their predecessors, but a new study finds the cost could come at up to 50 times more carbon emissions than their more basic equivalents. While the study's findings aren't definitive — emissions may vary depending on the hardware used and the energy grids used to supply their power — the researchers hope their work should prompt AI users to think before deploying the more advanced technology. Read more planet technology news —This EV battery fully recharges in just 18 seconds — and it just got the green light for mass production —Hurricanes and sandstorms can be forecast 5,000 times faster thanks to new Microsoft AI model —China pits rival humanoids against each other in world's first 'robot boxing tournament' —14,000-year-old ice age 'puppies' were actually wolf sisters that dined on woolly rhino for last meal —Nobel laureate raises questions about AI-generated image of black hole spinning at the heart of our galaxy —Enslaved Africans led a decade-long rebellion 1,200 years ago in Iraq, new evidence suggests —Covering poop lagoons with a tarp could cut 80% of methane emissions from dairy farms —Satellite coated in ultra-dark 'Vantablack' paint will launch into space next year to help combat major issue The Colorado River snakes through seven U.S. and two Mexican states, and supplies some 40 million people, including those in Phoenix and Las Vegas, with their water needs. But as supplies of this surface water reach record lows, more and more people have been pumping groundwater from far below the surface. Stark new satellite data reveal that the Colorado River basin has lost huge amounts of groundwater over the last few decades, with some research suggesting that this groundwater could run out by the end of the century. But is that really the case? And if so, what could be done to prevent that happening? —How to see the groundbreaking space photos from the world's largest camera [Astronomy] —Instead of 'de-extincting' dire wolves, scientists should use gene editing to protect living, endangered species [Opinion] —Crows: Facts about the clever birds that live all over the world [Fact file] —Best thermal binoculars: Observe nocturnal wildlife after dark [Buying guide] —Watch David Attenborough's 'Ocean' from anywhere in the world with this NordVPN deal — and grab an Amazon voucher just in time for Prime Day [Deal] A massive eruption at Indonesia's Mount Lewotobi Laki-laki volcano sent giant plumes of ash spewing more than 6 miles (10 kilometers) into the skies on Tuesday (June 17), followed by a second eruption just a day later. This incredible mushroom-shaped cloud could be seen over 95 miles (150 km) away, and was accompanied by rumbling, lightning and thunder, typical of explosive eruptions that spew enormous amounts of material — much of which showered over nearby villages. Warning signs at Lewoboti Laki-laki prompted officials to raise the eruption alert to the highest level on Tuesday, according to a statement, and fortunately at time of writing there have been no reports of casualties. Want more science news? Follow our Live Science WhatsApp Channel for the latest discoveries as they happen. It's the best way to get our expert reporting on the go, but if you don't use WhatsApp we're also on Facebook, X (formerly Twitter), Flipboard, Instagram, TikTok, Bluesky and LinkedIn.
Yahoo
14-06-2025
- Yahoo
There's a new blood test for Alzheimer's. Here's everything you need to know.
When you buy through links on our articles, Future and its syndication partners may earn a commission. The U.S. Food and Drug Administration (FDA) recently cleared a blood test that detects signs of Alzheimer's disease in the brain, according to multiple studies. This is the first-ever blood test available for this common form of dementia. Here's how the new blood test works and why it could be useful to patients. Alzheimer's disease is on the rise, in part because the age group most prone to dementia is growing larger. In the U.S., an estimated 7.2 million Americans ages 65 and older are living with Alzheimer's dementia in 2025. The percentage of affected people increases with age: About 5% of people ages 65 to 74 have Alzheimer's, compared with more than 33% of people ages 85 and older. At the point when a doctor has verified that a patient has cognitive decline, the blood test can be used in place of standard tests to see if they likely have Alzheimer's. Previously, gold-standard methods of diagnosing Alzheimer's have been more invasive and expensive, involving positron emission tomography (PET) scans, which use radioactive substances; and lumbar punctures, (also called spinal taps) during which a clinician uses a needle to sample spinal fluid from the low back. Clinicians also sometimes use MRIs or CT scans to rule out other causes of cognitive decline. The new test measures the ratio of two proteins in human blood, and this ratio correlates with the presence or absence of amyloid plaques, a primary sign of Alzheimer's found in the brain. For people experiencing memory lapses that might be due to Alzheimer's, the first step is to see their primary care physician (PCP), who should do a cognitive test. If there are signs of cognitive impairment, the patient would then be referred to a neurologist for an in-depth evaluation. Both dementia specialists and PCPs will be able to order this blood test to help with diagnosis, said Dr. Gregg Day, a neurologist with the Mayo Clinic in Jacksonville, Florida; Day led a study of the blood test published in June in the Journal of the Alzheimer's Association. A study published in 2024 in JAMA found that whether the test was ordered by a PCP or specialist, it was equally accurate at confirming suspected Alzheimer's diagnoses. PCPs could use the test results to decide whether to refer patients to a specialist, who could prescribe treatments such as lecanemab or donanemab, Day said. Or the PCP could personally prescribe a medicine like donepezil, which can help improve mental function in Alzheimer's. With FDA clearance, Medicare and private health insurance providers alike are expected to cover the new blood test, Day said. The test — called the "Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio" — is intended for people ages 55 and older who show signs and symptoms of cognitive decline that have been confirmed by a clinician. The test is designed for the early detection of amyloid plaques associated with Alzheimer's disease. (Amyloid plaques are unusual clumps found between brain cells and made up of a type of protein called beta-amyloid.) Related: Man nearly guaranteed to get early Alzheimer's is still disease-free in his 70s — how? Early detection is important, said Dr. Sayad Ausim Azizi, clinical chief of behavioral neurology and memory disorders at the Yale School of Medicine. That's because the Alzheimer's brain is like a rusty engine — the plaque is like rust settling onto the engine, interfering with the wheels' ability to turn, Azizi told Live Science. There are FDA-approved treatments that act like oil, helping the wheels to turn, but the medication does not remove the rust itself, he said. Available therapies can slow down the degradation of the brain by about 30% to 40%, studies show, so the patient can retain function for longer. "If you're driving now and living independently and you don't take the medicine, it's likely in five years you won't be able to do all these things," Azizi said, providing a hypothetical example. "If you take the medicine, the five years are extended to eight." If adopted as intended, the new blood test could help more people access these treatments sooner. The test is not recommended for the purposes of screening the general population. It is intended only for people who have been found by a doctor to exhibit signs of Alzheimer's disease, Day and Azizi emphasized. Some amount of amyloid is present in the brain during healthy aging, so its presence doesn't guarantee someone will later have Alzheimer's. If the test detects signs of amyloid plaques 20 years before any cognitive symptoms surface, Azizi explained, it would not make sense to treat the patient at that time. "The treatments are not 100% benign," he added. To receive lecanemab, for example, patients must be able to receive an infusion every two weeks at first and every four weeks later on; donanemab is given every four weeks. Both medications can come with infusion-related reactions, such as headache, nausea and vomiting. Rarely, the treatment donanemab can cause life-threatening allergic reactions, and both lecanemab and donanemab have been tied to rare cases of brain swelling or bleeding in the brain. These latter side effects are related to "amyloid-related imaging abnormalities," which are structural abnormalities that appear on brain scans. The new test can give false positives, meaning a person can potentially test positive when they don't actually have Alzheimer's. That's because the signs of amyloid that the tests look for can be tied to other conditions. For instance, amyloid buildup in the brain could be a sign the kidneys are not functioning optimally, Day said, so he recommends also doing a blood test for kidney function when ordering the Alzheimer's blood test. The Mayo Clinic study included about 510 people, 246 of whom showed cognitive decline; the blood test confirmed 95% of those with cognitive symptoms had Alzheimer's. About 5.3% of cases showed a false negative on the blood test, while 17.6% of cases gave a false positive, Day said. Most of the false-positive patients still had Alzheimer's-like changes in their brains, but their symptoms were ultimately attributed to other diseases, such as Lewy body dementia, Day said. The Mayo study found that the blood test helped doctors distinguish Alzheimer's from these other forms of dementia. As is true of many clinical trials, evaluations of the test have primarily included populations that are healthier than average, Day said. These individuals are not only healthier at baseline, but are more likely to have health insurance and be white and non-Hispanic. So when the blood test is used in a broader population, there may be people with sleep apnea or kidney disease who test positive despite not having Alzheimer's, Day said. Some people with these health problems may also experience memory issues or cognitive impairment that's not caused by Alzheimer's disease. If the blood test points to amyloid buildup, doctors could order additional tests and ask patients about their sleep to help rule out these other possibilities. RELATED STORIES —Could vaccines prevent and treat Alzheimer's disease? —Study unravels whole new layer of Alzheimer's disease —Alzheimer's comes in at least 5 distinct forms, study reveals The test will give researchers a more precise idea of how a patient's clinical symptoms relate to the findings on their blood test, Azizi said. "It's a great way of using a biomarker [measurable sign of disease] in the blood to make an earlier diagnosis to give a drug" to slow disease progression, he said. Azizi added that this blood test could help track whether a treatment for Alzheimer's disease is working, which would be useful both for patients receiving approved medicines and those in trials of new drugs. Looking forward, researchers will also be able to evaluate how well blood-based testing works in more diverse populations, Day noted. This article is for informational purposes only and is not meant to offer medical advice.
